ACHV vs NTLA: stock comparison and AI forecast
Achieve Life Sciences, Inc. (ACHV) and Intellia Therapeutics, Inc. (NTLA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACHV Achieve Life Sciences, Inc.
- Market Cap
- $693M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NTLA Intellia Therapeutics, Inc.
- Market Cap
- $1.75B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NTLA is 2.5 times larger than ACHV by market capitalization ($1.75B against $693M).
- Both companies share the SEC industry classification In Vitro & In Vivo Diagnostic Substances.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACHV | NTLA |
|---|---|---|
| Market Cap | $693M | $1.75B |
| P/B Ratio | – | 2.40x |
| EPS | $-1.68 | $-2.53 |
| Book Value/Share | – | $5.19 |
| Revenue/Share | – | $0.42 |
| FCF/Share | – | $-2.49 |
Profitability & Margins
| Metric | ACHV | NTLA |
|---|---|---|
| ROE | – | -55.0% |
| ROA | -59.9% | -46.7% |
| ROIC | – | -54.5% |
| Operating Margin | – | -711.7% |
| Net Margin | – | -672.2% |
| EBT Margin | – | -711.7% |
Financial Health
| Metric | ACHV | NTLA |
|---|---|---|
| Current Ratio | 0.95x | 6.65x |
| D/E Ratio | – | 0.18x |
| Financial Leverage | – | 1.18x |
| Working Capital | -$9M | $448M |
Cash Flow
| Metric | ACHV | NTLA |
|---|---|---|
| Operating Cash Flow | -$47M | -$347M |
| Free Cash Flow | – | -$349M |
| Capital Spending | – | -$2M |
| FCF/Sales | – | -586.0% |
| CapEx/Sales | – | 3.4% |
Operational Efficiency
| Metric | ACHV | NTLA |
|---|---|---|
| Asset Turnover | – | 0.07x |
| Receivables Turnover | – | 8.1x |
| Fixed Assets Turnover | – | 4.0x |
| Days Sales Outstanding | – | 45 days |
Income Statement
| Metric | ACHV | NTLA |
|---|---|---|
| Total Revenue | – | $60M |
| Operating Income | – | -$423M |
| Net Income | -$114M | -$400M |
| R&D Expense | $26M | $347M |
Dividend & Shareholder Information
| Metric | ACHV | NTLA |
|---|---|---|
| Shares Outstanding | 103M | 140M |
ACHV vs NTLA: stock comparison and AI forecast
Which is bigger, ACHV or NTLA?
NTLA is 2.5 times larger than ACHV by market capitalization ($1.75B against $693M).
Which one does Intratio's AI model rank higher, ACHV or NTLA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.